Publication | Closed Access
A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy
10
Citations
0
References
2017
Year
No additional data available for this publication yet. Check back later!